Octavian Bucur
Octavian Bucur
Harvard Medical School & Beth Israel Deaconess Medical Center
Verified email at - Homepage
Cited by
Cited by
Apoptotic cell signaling in cancer progression and therapy
J Plati, O Bucur, R Khosravi-Far
Integrative Biology 3 (4), 279-296, 2011
Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities
J Plati, O Bucur, R Khosravi‐Far
Journal of cellular biochemistry 104 (4), 1124-1149, 2008
Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy
Y Zhao, O Bucur, H Irshad, F Chen, A Weins, AL Stancu, EY Oh, ...
Nature biotechnology 35 (8), 757, 2017
Crowdsourcing Image Annotation for Nucleus Detection and Segmentationin Computational Pathology: Evaluating Experts, Automated Methods, and the Crowd
H Irshad, L Montaser-Kouhsari, G Waltz, O Bucur, NC Jones, F Dong, ...
Pacific Symposium on Biocomputing (PSB), 2015
Apoptotic pathways in tumor progression and therapy
A Melet, K Song, O Bucur, Z Jagani, AR Grassian, R Khosravi-Far
Programmed cell death in cancer progression and therapy, 47-79, 2008
Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT
A Singh, M Ye, O Bucur, S Zhu, MT Santos, I Rabinovitz, W Wei, D Gao, ...
Molecular Biology of the Cell 21 (6), 1140-1152, 2010
Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor
S Ray, O Bucur, A Almasan
Apoptosis 10 (6), 1411-1418, 2005
APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
O Bucur, S Ray, MC Bucur, A Almasan
Front Biosci 11, 1549-1568, 2006
A peroxidase peroxiredoxin 1-specific redox regulation of the novel FOXO3 microRNA target let-7
BL Hopkins, M Nadler, JJ Skoko, T Bertomeu, A Pelosi, PM Shafaei, ...
Antioxidants & redox signaling 28 (1), 62-77, 2018
Extensive rewiring of epithelial-stromal co-expression networks in breast cancer
EY Oh, SM Christensen, S Ghanta, JC Jeong, O Bucur, B Glass, ...
Genome biology 16 (1), 128, 2015
Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways
V Gunda, O Bucur, J Varnau, PV Borre, MJ Bernasconi, R Khosravi-Far, ...
Cell death & disease 5 (3), e1104, 2014
Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
MK Bhasin, K Ndebele, O Bucur, EU Yee, HH Otu, J Plati, A Bullock, X Gu, ...
Oncotarget, 2016
Nanoscale imaging of clinical specimens using conventional and rapid-expansion pathology
O Bucur, F Fu, M Calderon, GH Mylvaganam, NL Ly, J Day, S Watkin, ...
Nature Protocols, 1-24, 2020
A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death
O Bucur, G Gaidos, A Yatawara, B Pennarun, C Rupasinghe, J Roux, ...
Scientific Reports 5, e9893, 2015
Combination of bortezomib and mitotic inhibitors down-modulate bcr-abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant bcr-abl-positive leukemic cells
O Bucur, AL Stancu, I Goganau, SM Petrescu, B Pennarun, T Bertomeu, ...
PloS one 8 (10), e77390, 2013
PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor
O Bucur, AL Stancu, MS Muraru, A Melet, SM Petrescu, R Khosravi-Far
Discoveries 2 (2), e15, 2014
Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications
O Bucur, AL Stancu, R Khosravi-Far, A Almasan
Cell death & disease 3 (2), e263, 2012
Thyroid-related adverse events induced by immune checkpoint inhibitors
A Chera, AL Stancu, O Bucur
Frontiers in Endocrinology, 2277, 2022
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP
O Bucur, B Pennarun, AL Stancu, M Nadler, MS Muraru, T Bertomeu, ...
Apoptosis 18 (10), 1154-1162, 2013
killerFLIP: a novel lytic peptide specifically inducing cancer cell death
B Pennarun, G Gaidos, O Bucur, A Tinari, C Rupasinghe, T Jin, R Dewar, ...
Cell death & disease 4 (10), e894, 2013
The system can't perform the operation now. Try again later.
Articles 1–20